Clinical Trial Update: INcreTin-based thERapies for Cardiovascular Event PrevenTion in Patients With and Without ASCVD (INTERCEPT-ASCVD)

View source ↗

Summary

This clinical trial update describes INTERCEPT-ASCVD, a Brigham and Women's Hospital study evaluating incretin-based therapies for cardiovascular event preventi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atherosclerotic Cardiovascular Disease
• Type 2 Diabetes Mellitus

Snippet

Sponsor: Brigham and Women's Hospital | Conditions: Type 2 Diabetes, Overweight | Status: ACTIVE_NOT_RECRUITING